MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Clinical trial NCT06150417 · RECRUITING

Trial details

NCT number: NCT06150417
Sponsor: Case Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Malignant Neoplasm of Prostate Secondary Malignant Neoplasm of Prostate

Start date: 2024-07-01
Primary completion: 2028-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.